Today: 29 April 2026
Browse Category

NASDAQ:LEGN 8 December 2025 - 24 February 2026

Legend Biotech (LEGN) stock slips in premarket after 9% surge as Gilead-Arcellx deal spotlights Carvykti rivals

Legend Biotech (LEGN) stock slips in premarket after 9% surge as Gilead-Arcellx deal spotlights Carvykti rivals

Legend Biotech shares slipped 0.2% to $19.72 in premarket trading Tuesday after a 9% jump the previous session, following news of Gilead’s $7.8 billion deal to buy Arcellx. The acquisition put focus on rival CAR-T therapies, with Arcellx’s anito-cel under FDA review and analysts citing possible safety advantages over Legend’s Carvykti, which generated $1.9 billion in 2025 sales.
24 February 2026
·
Arcellx stock surges toward $115 buyout price after Gilead deal sets new ceiling

Arcellx stock surges toward $115 buyout price after Gilead deal sets new ceiling

Arcellx shares surged 78% to $113.92 after Gilead Sciences agreed to acquire the company for $115 per share in cash, plus a $5 contingent payout tied to anito-cel sales, valuing Arcellx at up to $7.8 billion. The companies expect to close the deal in Q2 2026. Trading volume in Arcellx topped 11 million shares by mid-morning. Gilead shares fell 0.5%.
23 February 2026
····
Legend Biotech stock hits a fresh 52-week low as biotech lags — JPMorgan update looms

Legend Biotech stock hits a fresh 52-week low as biotech lags — JPMorgan update looms

Legend Biotech shares dropped 4.7% to $20.49 Monday, hitting a 52-week low and leaving the stock down 55% from its high. The decline comes ahead of the J.P. Morgan Healthcare Conference, where CEO Ying Huang is set to present Jan. 14. Broader biotech stocks also fell, with key ETFs down about 1%. Investors are watching for updates on CARVYKTI, Legend’s CAR-T therapy for multiple myeloma.
5 January 2026
·
Biggest Stock Losers Today in the U.S. (Dec. 10, 2025): DYN, SLM, KTB, WAY and More Slide as Fed Decision Looms

Biggest Stock Losers Today in the U.S. (Dec. 10, 2025): DYN, SLM, KTB, WAY and More Slide as Fed Decision Looms

Dyne Therapeutics shares fell 16.9% to $18.44 after announcing a $300 million stock offering. SLM Corp dropped 15%, Kontoor Brands slid 9.5%, and Waystar Holding lost 8.4%. Major indexes were little changed as investors awaited the Federal Reserve’s interest-rate decision. The U.S. 10-year Treasury yield hovered near 4.19%.
10 December 2025
···········
Biggest Stock Losers Today: LEGN, MRVL, UL and More Slide as Wall Street Braces for a Fed Rate Cut (December 8, 2025)

Biggest Stock Losers Today: LEGN, MRVL, UL and More Slide as Wall Street Braces for a Fed Rate Cut (December 8, 2025)

Legend Biotech fell 12.8% to a new 52-week low Monday, leading U.S. stock declines as the S&P 500 hovered just below record highs ahead of the Fed’s rate decision. Marvell Technology dropped 8.6%, Unilever ADR lost 7%, and several others slid 4–6%. Traders priced in an 85–90% chance of a 25-basis-point Fed rate cut this week.
8 December 2025
············

Stock Market Today

  • General Dynamics Q1 CY2026 Earnings Beat Expectations with 10.3% Revenue Growth
    April 29, 2026, 8:48 AM EDT. General Dynamics (NYSE:GD) reported strong first-quarter results for calendar year 2026, with revenue of $13.48 billion, beating analyst estimates by 5.9%. The aerospace and defense firm posted a GAAP earnings per share (EPS) of $4.10, 11% above consensus. Adjusted EBITDA reached $1.59 billion, surpassing forecasts. The company's backlog climbed 47.5% year-on-year to $130.8 billion, signaling robust demand despite potential capacity constraints. Free cash flow swung positively to $1.95 billion from a negative figure last year. CEO Phebe Novakovic highlighted solid operating results and cash conversion. While long-term growth averaged 6.9% annually over five years, recent two-year revenue growth accelerated to 11.7%. Analysts project a more modest 3% revenue increase in the next 12 months, indicating possible near-term demand challenges.

Latest article

Bloom Energy Stock in Focus After Record Q1 Earnings and Oracle AI Power Deal

Bloom Energy Stock in Focus After Record Q1 Earnings and Oracle AI Power Deal

29 April 2026
Bloom Energy raised its 2026 revenue forecast to $3.4–$3.8 billion after first-quarter revenue surged 130% to $751.1 million, beating analyst estimates. Net profit reached $70.7 million, reversing a year-ago loss. Oracle and BorderPlex said their New Mexico data center project will use up to 2.45 GW of Bloom fuel-cell capacity. Shares last traded at $226.37, down $8.36 before the market opened.
BigBear.ai Stock Jumps 10% Before Earnings: Why BBAI Is Back on Traders’ Screens

BigBear.ai Stock Jumps 10% Before Earnings: Why BBAI Is Back on Traders’ Screens

29 April 2026
BigBear.ai shares jumped 10.46% to close at $4.12 Tuesday, with trading volume 54% above its three-month average. The company will report first-quarter results after markets close on May 5. Analysts expect a quarterly loss and revenue near $33.6 million. The move comes as AI stocks face pressure following reports of missed targets at OpenAI.
Gas Prices Hit $4.23 as Iran Oil Shock Reaches U.S. Pumps

Gas Prices Hit $4.23 as Iran Oil Shock Reaches U.S. Pumps

29 April 2026
U.S. average gasoline prices rose to $4.229 a gallon Wednesday, up 21 cents from a week ago, AAA reported. Brent crude climbed above $114 as traders reacted to ongoing disruptions near Iran and the Strait of Hormuz. Refineries in the Midwest faced outages, tightening supply. The Federal Reserve is expected to hold rates steady as officials monitor energy-driven inflation.
Go toTop